-
1
-
-
79952232216
-
Global cancer statistics
-
Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
-
(2011)
CA Cancer J Clin
, vol.61
, pp. 69-90
-
-
Jemal, A.1
Bray, F.2
Center, M.M.3
Ferlay, J.4
Ward, E.5
Forman, D.6
-
2
-
-
4744344066
-
Epigenetics and cancer
-
Lund AH and van Lohuizen M: Epigenetics and cancer. Genes Dev 18: 2315-2335, 2004.
-
(2004)
Genes Dev
, vol.18
, pp. 2315-2335
-
-
Lund, A.H.1
Van Lohuizen, M.2
-
3
-
-
35349020543
-
Transcriptional silencing of hedgehog-interacting protein by cpg hypermethylation and chromatic structure in human gastrointestinal cancer
-
Taniguchi H, Yamamoto H, Akutsu N, et al: Transcriptional silencing of hedgehog-interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer. J Pathol 213: 131-139, 2007.
-
(2007)
J Pathol
, vol.213
, pp. 131-139
-
-
Taniguchi, H.1
Yamamoto, H.2
Akutsu, N.3
-
4
-
-
34249774568
-
Transcriptional silencing of the tms1/asc tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells
-
Zhang C, Li H, Zhou G, et al: Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells. J Pathol 212: 134-142, 2007.
-
(2007)
J Pathol
, vol.212
, pp. 134-142
-
-
Zhang, C.1
Li, H.2
Zhou, G.3
-
5
-
-
50249175130
-
Loss of trimethylation at lysine 27 of histone h3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers
-
Wei Y, Xia W, Zhang Z, et al: Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers. Mol Carcinog 47: 701-706, 2008.
-
(2008)
Mol Carcinog
, vol.47
, pp. 701-706
-
-
Wei, Y.1
Xia, W.2
Zhang, Z.3
-
6
-
-
11144286644
-
Histone h3 acetylation is associated with reduced p21(waf1/cip1) expression by gastric carcinoma
-
Mitani Y, Oue N, Hamai Y, et al: Histone H3 acetylation is associated with reduced p21(WAF1/CIP1) expression by gastric carcinoma. J Pathol 205: 65-73, 2005.
-
(2005)
J Pathol
, vol.205
, pp. 65-73
-
-
Mitani, Y.1
Oue, N.2
Hamai, Y.3
-
7
-
-
33847076849
-
Chromatin modifications and their function
-
Kouzarides T: Chromatin modifications and their function. Cell 128: 693-705, 2007.
-
(2007)
Cell
, vol.128
, pp. 693-705
-
-
Kouzarides, T.1
-
8
-
-
67650898226
-
The histone deacetylase inhibitor lbh589 inhibits expression of mitotic genes causing g2/m arrest and cell death in head and neck squamous cell carcinoma cell lines
-
Prystowsky MB, Adomako A, Smith RV, et al: The histone deacetylase inhibitor LBH589 inhibits expression of mitotic genes causing G2/M arrest and cell death in head and neck squamous cell carcinoma cell lines. J Pathol 218: 467-477, 2009.
-
(2009)
J Pathol
, vol.218
, pp. 467-477
-
-
Prystowsky, M.B.1
Adomako, A.2
Smith, R.V.3
-
9
-
-
33846569960
-
A stem cell-like chromatin pattern may predispose tumor suppressor genes to dna hypermethylation and heritable silencing
-
Ohm JE, McGarvey KM, Yu X, et al: A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet 39: 237-242, 2007.
-
(2007)
Nat Genet
, vol.39
, pp. 237-242
-
-
Ohm, J.E.1
McGarvey, K.M.2
Yu, X.3
-
10
-
-
33846649587
-
Polycomb-mediated methylation on lys27 of histone h3 pre-marks genes for de novo methylation in cancer
-
Schlesinger Y, Straussman R, Keshet I, et al: Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat Genet 39: 232-236, 2007.
-
(2007)
Nat Genet
, vol.39
, pp. 232-236
-
-
Schlesinger, Y.1
Straussman, R.2
Keshet, I.3
-
11
-
-
32844459336
-
The polycomb group protein ezh2 directly controls dna methylation
-
Vire E, Brenner C, Deplus R, et al: The Polycomb group protein EZH2 directly controls DNA methylation. Nature 439: 871-874, 2006.
-
(2006)
Nature
, vol.439
, pp. 871-874
-
-
Vire, E.1
Brenner, C.2
Deplus, R.3
-
12
-
-
77649246145
-
Histone modification levels are predictive for gene expression
-
Karlic R, Chung HR, Lasserre J, Vlahovicek K and Vingron M: Histone modification levels are predictive for gene expression. Proc Natl Acad Sci USA 107: 2926-2931, 2010.
-
(2010)
Proc Natl Acad Sci USA
, vol.107
, pp. 2926-2931
-
-
Karlic, R.1
Chung, H.R.2
Lasserre, J.3
Vlahovicek, K.4
Vingron, M.5
-
13
-
-
82555173684
-
EZH2 methyltransferase and h3k27 methylation in breast cancer
-
Yoo KH and Hennighausen L: EZH2 methyltransferase and H3K27 methylation in breast cancer. Int J Biol Sci 8: 59-65, 2012.
-
(2012)
Int J Biol Sci
, vol.8
, pp. 59-65
-
-
Yoo, K.H.1
Hennighausen, L.2
-
14
-
-
78651506355
-
High expression of h3k27me3 in human hepatocellular carcinomas correlates closely with vascular invasion and predicts worse prognosis in patients
-
Cai MY, Hou JH, Rao HL, et al: High expression of H3K27me3 in human hepatocellular carcinomas correlates closely with vascular invasion and predicts worse prognosis in patients. Mol Med 17: 12-20, 2011.
-
(2011)
Mol Med
, vol.17
, pp. 12-20
-
-
Cai, M.Y.1
Hou, J.H.2
Rao, H.L.3
-
15
-
-
84856110196
-
Global histone h3k27 methylation levels are different in localized and metastatic prostate cancer
-
Ellinger J, Kahl P, von der Gathen J, et al: Global histone H3K27 methylation levels are different in localized and metastatic prostate cancer. Cancer Invest 30: 92-97, 2012.
-
(2012)
Cancer Invest
, vol.30
, pp. 92-97
-
-
Ellinger, J.1
Kahl, P.2
Von Der Gathen, J.3
-
16
-
-
79955470771
-
The h3k27me3 demethylase, kdm6b, is induced by epstein-barr virus and over-expressed in hodgkin's lymphoma
-
Anderton JA, Bose S, Vockerodt M, et al: The H3K27me3 demethylase, KDM6B, is induced by Epstein-Barr virus and over-expressed in Hodgkin's lymphoma. Oncogene 30: 2037-2043, 2011.
-
(2011)
Oncogene
, vol.30
, pp. 2037-2043
-
-
Anderton, J.A.1
Bose, S.2
Vockerodt, M.3
-
17
-
-
59149096527
-
Prognostic significance of global histone modifications in resected squamous cell carcinoma of the esophagus
-
Tzao C, Tung HJ, Jin JS, et al: Prognostic significance of global histone modifications in resected squamous cell carcinoma of the esophagus. Mod Pathol 22: 252-260, 2009.
-
(2009)
Mod Pathol
, vol.22
, pp. 252-260
-
-
Tzao, C.1
Tung, H.J.2
Jin, J.S.3
-
18
-
-
82855172243
-
H3K27me3 protein is a promising predictive biomarker of patients' survival and chemoradioresistance in human nasopharyngeal carcinoma
-
Cai MY, Tong ZT, Zhu W, et al: H3K27me3 protein is a promising predictive biomarker of patients' survival and chemoradioresistance in human nasopharyngeal carcinoma. Mol Med 17: 1137-1145, 2011.
-
(2011)
Mol Med
, vol.17
, pp. 1137-1145
-
-
Cai, M.Y.1
Tong, Z.T.2
Zhu, W.3
-
19
-
-
79955513100
-
Aberrations of ezh2 in cancer
-
Chase A and Cross NC: Aberrations of EZH2 in cancer. Clin Cancer Res 17: 2613-2618, 2011.
-
(2011)
Clin Cancer Res
, vol.17
, pp. 2613-2618
-
-
Chase, A.1
Cross, N.C.2
-
20
-
-
79959267832
-
Validation of the histone methyltransferase ezh2 as a therapeutic target for various types of human cancer and as a prognostic marker
-
Takawa M, Masuda K, Kunizaki M, et al: Validation of the histone methyltransferase EZH2 as a therapeutic target for various types of human cancer and as a prognostic marker. Cancer Sci 102: 1298-1305, 2011.
-
(2011)
Cancer Sci
, vol.102
, pp. 1298-1305
-
-
Takawa, M.1
Masuda, K.2
Kunizaki, M.3
-
21
-
-
84857998198
-
Enhancer of zeste homolog 2 is a novel prognostic biomarker in nonsmall cell lung cancer
-
Huqun, Ishikawa R, Zhang J, et al: Enhancer of zeste homolog 2 is a novel prognostic biomarker in nonsmall cell lung cancer. Cancer 118: 1599-1606, 2012.
-
(2012)
Cancer
, vol.118
, pp. 1599-1606
-
-
Huqun Ishikawa, R.1
Zhang, J.2
-
22
-
-
82555176159
-
Polycomb group protein ezh2 is frequently expressed in inflammatory breast cancer and is predictive of worse clinical outcome
-
Gong Y, Huo L, Liu P, et al: Polycomb group protein EZH2 is frequently expressed in inflammatory breast cancer and is predictive of worse clinical outcome. Cancer 117: 5476-5484, 2011.
-
(2011)
Cancer
, vol.117
, pp. 5476-5484
-
-
Gong, Y.1
Huo, L.2
Liu, P.3
-
23
-
-
0141816752
-
EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells
-
Kleer CG, Cao Q, Varambally S, et al: EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc Natl Acad Sci USA 100: 11606-11611, 2003.
-
(2003)
Proc Natl Acad Sci USA
, vol.100
, pp. 11606-11611
-
-
Kleer, C.G.1
Cao, Q.2
Varambally, S.3
-
24
-
-
78651454089
-
EZH2 promotes expansion of breast tumor initiating cells through activation of raf1-beta-catenin signaling
-
Chang CJ, Yang JY, Xia W, et al: EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-beta-catenin signaling. Cancer Cell 19: 86-100, 2011.
-
(2011)
Cancer Cell
, vol.19
, pp. 86-100
-
-
Chang, C.J.1
Yang, J.Y.2
Xia, W.3
-
25
-
-
79957891885
-
EZH2 and aldh-1 mark breast epithelium at risk for breast cancer development
-
Kunju LP, Cookingham C, Toy KA, Chen W, Sabel MS and Kleer CG: EZH2 and ALDH-1 mark breast epithelium at risk for breast cancer development. Mod Pathol 24: 786-793, 2011.
-
(2011)
Mod Pathol
, vol.24
, pp. 786-793
-
-
Kunju, L.P.1
Cookingham, C.2
Toy, K.A.3
Chen, W.4
Sabel, M.S.5
Kleer, C.G.6
-
26
-
-
84859099474
-
Increased risk for distant metastasis in patients with familial early-stage breast cancer and high ezh2 expression
-
Alford SH, Toy K, Merajver SD and Kleer CG: Increased risk for distant metastasis in patients with familial early-stage breast cancer and high EZH2 expression. Breast Cancer Res Treat 132: 429-437, 2012.
-
(2012)
Breast Cancer Res Treat
, vol.132
, pp. 429-437
-
-
Alford, S.H.1
Toy, K.2
Merajver, S.D.3
Kleer, C.G.4
-
27
-
-
33644822360
-
EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast
-
Bachmann IM, Halvorsen OJ, Collett K, et al: EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast. J Clin Oncol 24: 268-273, 2006.
-
(2006)
J Clin Oncol
, vol.24
, pp. 268-273
-
-
Bachmann, I.M.1
Halvorsen, O.J.2
Collett, K.3
-
28
-
-
84855989975
-
RAS oncogenic signal upregulates ezh2 in pancreatic cancer
-
Fujii S, Fukamachi K, Tsuda H, Ito K, Ito Y and Ochiai A: RAS oncogenic signal upregulates EZH2 in pancreatic cancer. Biochem Biophys Res Commun 417: 1074-1079, 2012.
-
(2012)
Biochem Biophys Res Commun
, vol.417
, pp. 1074-1079
-
-
Fujii, S.1
Fukamachi, K.2
Tsuda, H.3
Ito, K.4
Ito, Y.5
Ochiai, A.6
-
29
-
-
79951723134
-
EZH2 regulates expression of p57 and contributes to progression of ovarian cancer in vitro and in vivo
-
Guo J, Cai J, Yu L, Tang H, Chen C and Wang Z: EZH2 regulates expression of p57 and contributes to progression of ovarian cancer in vitro and in vivo. Cancer Sci 102: 530-539, 2011.
-
(2011)
Cancer Sci
, vol.102
, pp. 530-539
-
-
Guo, J.1
Cai, J.2
Yu, L.3
Tang, H.4
Chen, C.5
Wang, Z.6
-
30
-
-
54049121723
-
In situ detection of methylated dna by histo endonuclease-linked detection of methylated dna sites: A new principle of analysis of dna methylation
-
Koji T, Kondo S, Hishikawa Y, An S and Sato Y: In situ detection of methylated DNA by histo endonuclease-linked detection of methylated DNA sites: a new principle of analysis of DNA methylation. Histochem Cell Biol 130: 917-925, 2008.
-
(2008)
Histochem Cell Biol
, vol.130
, pp. 917-925
-
-
Koji, T.1
Kondo, S.2
Hishikawa, Y.3
An, S.4
Sato, Y.5
-
31
-
-
18744396688
-
Induction of cell death in rat small intestine by ischemia reperfusion: Differential roles of fasfas ligand and bcl-2bax systems depending upon cell types
-
An S, Hishikawa Y and Koji T: Induction of cell death in rat small intestine by ischemia reperfusion: differential roles of Fas/Fas ligand and Bcl-2/Bax systems depending upon cell types. Histochem Cell Biol 123: 249-261, 2005.
-
(2005)
Histochem Cell Biol
, vol.123
, pp. 249-261
-
-
An, S.1
Hishikawa, Y.2
Koji, T.3
-
32
-
-
72849126461
-
Human papillomavirus infection and its possible correlation with p63 expression in cervical cancer in japan, mongolia, and myanmar
-
Shirendeb U, Hishikawa Y, Moriyama S, et al: Human papillomavirus infection and its possible correlation with p63 expression in cervical cancer in Japan, Mongolia, and Myanmar. Acta Histochem Cytochem 42: 181-190, 2009.
-
(2009)
Acta Histochem Cytochem
, vol.42
, pp. 181-190
-
-
Shirendeb, U.1
Hishikawa, Y.2
Moriyama, S.3
-
33
-
-
80052162130
-
Immunohistochemical analysis of histone h3 modifications in germ cells during mouse spermatogenesis
-
Song N, Liu J, An S, Nishino T, Hishikawa Y and Koji T: Immunohistochemical analysis of histone H3 modifications in germ cells during mouse spermatogenesis. Acta Histochem Cytochem 44: 183-190, 2011.
-
(2011)
Acta Histochem Cytochem
, vol.44
, pp. 183-190
-
-
Song, N.1
Liu, J.2
An, S.3
Nishino, T.4
Hishikawa, Y.5
Koji, T.6
-
34
-
-
0007384405
-
Heavy metal intensification of dab-based hrp reaction product
-
Adams JC: Heavy metal intensification of DAB-based HRP reaction product. J Histochem Cytochem 29: 775, 1981.
-
(1981)
J Histochem Cytochem
, vol.29
, pp. 775
-
-
Adams, J.C.1
-
35
-
-
4544233936
-
Expression of keratinocyte growth factor/fibroblast growth factor-7 and its receptor in human lung cancer: Correlation with tumour proliferative activity and patient prognosis
-
Yamayoshi T, Nagayasu T, Matsumoto K, Abo T, Hishikawa Y and Koji T: Expression of keratinocyte growth factor/fibroblast growth factor-7 and its receptor in human lung cancer: correlation with tumour proliferative activity and patient prognosis. J Pathol 204: 110-118, 2004.
-
(2004)
J Pathol
, vol.204
, pp. 110-118
-
-
Yamayoshi, T.1
Nagayasu, T.2
Matsumoto, K.3
Abo, T.4
Hishikawa, Y.5
Koji, T.6
-
36
-
-
8444244786
-
X-tile: A new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization
-
Camp RL, Dolled-Filhart M and Rimm DL: X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res 10: 7252-7259, 2004.
-
(2004)
Clin Cancer Res
, vol.10
, pp. 7252-7259
-
-
Camp, R.L.1
Dolled-Filhart, M.2
Rimm, D.L.3
-
37
-
-
84855942931
-
Global histone h3 lysine 27 (h3k27) methylation levels and their prognostic relevance in renal cell carcinoma
-
Rogenhofer S, Kahl P, Mertens C, et al: Global histone H3 lysine 27 (H3K27) methylation levels and their prognostic relevance in renal cell carcinoma. BJU Int 109: 459-465, 2012.
-
(2012)
BJU Int
, vol.109
, pp. 459-465
-
-
Rogenhofer, S.1
Kahl, P.2
Mertens, C.3
-
38
-
-
84866050864
-
Global h3k27 trimethylation and ezh2 abundance in breast tumor subtypes
-
Holm K, Grabau D, Lovgren K, et al: Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes. Mol Oncol 6: 494-506, 2012.
-
(2012)
Mol Oncol
, vol.6
, pp. 494-506
-
-
Holm, K.1
Grabau, D.2
Lovgren, K.3
-
39
-
-
20444475352
-
Down-regulation of human dab2ip gene expression mediated by polycomb ezh2 complex and histone deacetylase in prostate cancer
-
Chen H, Tu SW and Hsieh JT: Down-regulation of human DAB2IP gene expression mediated by polycomb Ezh2 complex and histone deacetylase in prostate cancer. J Biol Chem 280: 22437-22444, 2005.
-
(2005)
J Biol Chem
, vol.280
, pp. 22437-22444
-
-
Chen, H.1
Tu, S.W.2
Hsieh, J.T.3
-
40
-
-
13844315463
-
Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation
-
Kuzmichev A, Margueron R, Vaquero A, et al: Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation. Proc Natl Acad Sci USA 102: 1859-1864, 2005.
-
(2005)
Proc Natl Acad Sci USA
, vol.102
, pp. 1859-1864
-
-
Kuzmichev, A.1
Margueron, R.2
Vaquero, A.3
-
41
-
-
1942503942
-
The functions of e(z)/ezh2-mediated methylation of lysine 27 in histone h3
-
Cao R and Zhang Y: The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3. Curr Opin Genet Dev 14: 155-164, 2004.
-
(2004)
Curr Opin Genet Dev
, vol.14
, pp. 155-164
-
-
Cao, R.1
Zhang, Y.2
-
42
-
-
1942502862
-
Different ezh2-containing complexes target methylation of histone h1 or nucleosomal histone h3
-
Kuzmichev A, Jenuwein T, Tempst P and Reinberg D: Different EZH2-containing complexes target methylation of histone H1 or nucleosomal histone H3. Mol Cell 14: 183-193, 2004.
-
(2004)
Mol Cell
, vol.14
, pp. 183-193
-
-
Kuzmichev, A.1
Jenuwein, T.2
Tempst, P.3
Reinberg, D.4
-
43
-
-
0025716265
-
DNA methylation and specific protein-dna interactions
-
Molloy PL and Watt F: DNA methylation and specific protein-DNA interactions. Philos Trans R Soc Lond B Biol Sci 326: 267-275, 1990.
-
(1990)
Philos Trans R Soc Lond B Biol Sci
, vol.326
, pp. 267-275
-
-
Molloy, P.L.1
Watt, F.2
-
44
-
-
77954137460
-
Hypomethylation of repeated dna sequences in cancer
-
Ross JP, Rand KN and Molloy PL: Hypomethylation of repeated DNA sequences in cancer. Epigenomics 2: 245-269, 2010.
-
(2010)
Epigenomics
, vol.2
, pp. 245-269
-
-
Ross, J.P.1
Rand, K.N.2
Molloy, P.L.3
-
45
-
-
20344405446
-
DNA methylation disturbances as novel therapeutic target in lung cancer: Preclinical and clinical results
-
Digel W and Lubbert M: DNA methylation disturbances as novel therapeutic target in lung cancer: preclinical and clinical results. Crit Rev Oncol Hematol 55: 1-11, 2005.
-
(2005)
Crit Rev Oncol Hematol
, vol.55
, pp. 1-11
-
-
Digel, W.1
Lubbert, M.2
-
46
-
-
33846111256
-
Alteration of dna methyltransferases contributes to 5'cpg methylation and poor prognosis in lung cancer
-
Lin RK, Hsu HS, Chang JW, Chen CY, Chen JT and Wang YC: Alteration of DNA methyltransferases contributes to 5'CpG methylation and poor prognosis in lung cancer. Lung Cancer 55: 205-213, 2007.
-
(2007)
Lung Cancer
, vol.55
, pp. 205-213
-
-
Lin, R.K.1
Hsu, H.S.2
Chang, J.W.3
Chen, C.Y.4
Chen, J.T.5
Wang, Y.C.6
|